BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16522372)

  • 1. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
    Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
    Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional CD40 in human hepatocellular carcinoma.
    Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
    Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
    Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
    Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
    Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
    Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
    Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
    Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
    Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
    Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
    Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
    Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
    Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
    Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
    Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
    Yano H; Yanai Y; Momosaki S; Ogasawara S; Akiba J; Kojiro S; Moriya F; Fukahori S; Kurimoto M; Kojiro M
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1720-5. PubMed ID: 16984596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
    Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
    Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C.
    Wang XY; Crowston JG; Zoellner H; Healey PR
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3655-61. PubMed ID: 17652735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.